The present invention consists of a self-contained bioreactor that allows monitoring of cell activities exposed to various physical, chemical, and mechanical stimuli, both under isobaric conditions and in the presence of controlled flows.
The invention consists of a method to activate cyclic AMP (cAMP)-mediated intracellular response in renal cells by triggering the beta-3 subtype adrenergic receptor (BAR3).
The present invention provides an in vitro and ex vivo method using novel diagnostic probes with a specific spectrum detected by infrared (IR) spectroscopy.
The invention concerns a system based on a nano-transducer able to modify a target DNA sequence in a cell in order to delete harmful mutations underlying genetic diseases.
The new patented compounds are based on a potent reversible noncovalent mechanism of action, which is useful for treating MAGL-mediated diseases, such as neuroinflammation/degeneration, pain, multiple sclerosis/amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease.
The invention consists of a novel experimental set-up for the muscular rehabilitation of the tongue, which is necessary for the restoration of motility and physiological function of the organ for the purpose of adequate swallowing in patients, who are post-stroke or otherwise have impaired tongue motility.
The present invention relates to the automation of data interpretation from a chromatography analysis, such specifically the retention times and concentration values of analytes in a mixture.
The present invention relates to the development of novel isoindoline derivatives as activators of AMPK (Adenosine MonoPhosphate-activated protein Kinase), a key enzyme in cellular metabolism. The compounds, with original chemical structure, can be usefully employed for the prevention and treatment of metabolic disorders, such as type II diabetes and obesity, as well as immune-mediated inflammatory diseases and cancer.
The present invention relates to the development of novel benzofuran derivatives able to activate AMPK (Adenosine MonoPhosphate-activated protein Kinase), a key enzyme in the regulation of immune homeostasis
The present invention relates to novel benzo[d]isothiazolic-3(2H)-one-1,1-dioxide core compounds able to effectively and selectively inhibiting the IX and XII isoforms of the enzyme carbonic anhydrase (CA), which are predominantly expressed in hypoxic and metastatic tumors.
